Connor, Clark & Lunn Investment Management (CC&L)’s Editas Medicine EDIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-85,098
| Closed | -$397K | – | 1495 |
|
|
2024
Q2 | $397K | Sell |
85,098
-90,457
| -52% | -$422K | ﹤0.01% | 1110 |
|
|
2024
Q1 | $1.3M | Buy |
175,555
+160,974
| +1,104% | +$1.19M | 0.01% | 800 |
|
|
2023
Q4 | $148K | Buy |
+14,581
| New | +$148K | ﹤0.01% | 1291 |
|
|
2022
Q4 | – | Sell |
-240,244
| Closed | -$2.94M | – | 1275 |
|
|
2022
Q3 | $2.94M | Buy |
240,244
+4,028
| +2% | +$49.3K | 0.02% | 421 |
|
|
2022
Q2 | $2.79M | Buy |
236,216
+53,731
| +29% | +$636K | 0.02% | 419 |
|
|
2022
Q1 | $3.47M | Buy |
182,485
+108,848
| +148% | +$2.07M | 0.02% | 389 |
|
|
2021
Q4 | $1.96M | Sell |
73,637
-47,448
| -39% | -$1.26M | 0.01% | 539 |
|
|
2021
Q3 | $4.97M | Buy |
121,085
+14,568
| +14% | +$598K | 0.03% | 342 |
|
|
2021
Q2 | $6.03M | Buy |
106,517
+47,498
| +80% | +$2.69M | 0.03% | 319 |
|
|
2021
Q1 | $2.48M | Buy |
+59,019
| New | +$2.48M | 0.01% | 512 |
|